To infect our cells, SARS-CoV-2’s spike protein turns the key on the molecular doorway formed…
dcorriganFebruary 7, 2022
Seagen announced that the Phase III ECHELON-1 clinical trial demonstrated a statistically significant improvement in…
dcorriganFebruary 4, 2022
Liver Institute Northwest is enrolling participants into RESPONSE, a global phase 3 clinical research study…
dcorriganFebruary 2, 2022
Moez Dawood has numerous opportunities to explore saturation genome editing working alongside BBI’s Dr. Lea…
dcorriganJanuary 31, 2022
About 470,000 children in the United States are diagnosed with epilepsy, or 6.3 out of…
dcorriganJanuary 31, 2022
In adults who had previously received a full regimen of a COVID-19 vaccine approved or…
dcorriganJanuary 31, 2022
Researchers worldwide, including many at Fred Hutchinson Cancer Research Center and the University of Washington,…
dcorriganJanuary 28, 2022
An international team of scientists has determined the precise structural changes in the spike protein…
dcorriganJanuary 28, 2022
Today we report in Science the design of new protein assemblies made from modular parts. These complexes…
dcorriganJanuary 28, 2022
